ONCOCYTE CORP's ticker is OCX and the CUSIP is 68235C107. A total of 2 filers reported holding ONCOCYTE CORP in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $357,302 | -33.2% | 114,520 | -95.1% | 0.13% | -29.9% |
| Q2 2023 | $535,113 | -36.1% | 2,327,930 | -1.5% | 0.18% | -37.2% |
| Q1 2023 | $837,600 | +14.8% | 2,363,430 | +4.0% | 0.29% | -0.7% |
| Q4 2022 | $729,383 | -61.3% | 2,272,930 | -10.9% | 0.30% | -60.0% |
| Q3 2022 | $1,883,000 | -19.2% | 2,551,980 | -1.4% | 0.74% | -19.3% |
| Q2 2022 | $2,330,000 | -41.8% | 2,589,380 | +1.1% | 0.91% | -34.3% |
| Q1 2022 | $4,001,000 | -16.8% | 2,562,130 | +15.6% | 1.39% | -9.8% |
| Q4 2021 | $4,811,000 | -30.6% | 2,216,800 | +13.1% | 1.54% | -31.6% |
| Q3 2021 | $6,935,000 | -10.3% | 1,960,820 | +45.5% | 2.26% | -12.2% |
| Q2 2021 | $7,732,000 | +147.7% | 1,347,200 | +122.9% | 2.57% | +130.6% |
| Q1 2021 | $3,122,000 | – | 604,450 | – | 1.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BROADWOOD CAPITAL INC | 14,716,204 | $20,456,000 | 1.61% |
| PURA VIDA INVESTMENTS, LLC | 6,022,534 | $8,371,000 | 0.43% |
| P.A.W. CAPITAL CORP | 199,700 | $278,000 | 0.30% |
| Penbrook Management LLC | 229,425 | $319,000 | 0.28% |
| PERKINS CAPITAL MANAGEMENT INC | 39,725 | $55,000 | 0.05% |
| GSA CAPITAL PARTNERS LLP | 201,047 | $279,000 | 0.05% |
| Private Wealth Partners, LLC | 150,000 | $209,000 | 0.02% |
| Phoenix Holdings Ltd. | 317,138 | $426,000 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 255,300 | $355,000 | 0.01% |
| ETF MANAGERS GROUP, LLC | 157,933 | $226,000 | 0.01% |